Report Code : CVMI24071617 | Published Date : July 16, 2024
The Trulicity Market is experiencing significant growth, driven by the rising prevalence of diabetes, the increasing adoption of GLP-1 receptor agonists, and advancements in long-acting injectable therapies. Valued at USD XX billion in 2023, the market is projected to grow at a CAGR of XX% from 2024 to 2031, reaching USD XX billion by 2031.
Trulicity Market Key Insights
Trulicity (dulaglutide) has emerged as a leading GLP-1 receptor agonist for managing type 2 diabetes, offering once-weekly dosing and proven cardiovascular benefits. With the increasing shift toward non-insulin injectable therapies, Trulicity is seeing widespread adoption among diabetic and pre-diabetic patients. Pharmaceutical companies are also investing in combination therapies and next-generation formulations to enhance patient compliance and efficacy.
Trulicity Market Growth Drivers
- Increasing Diabetes Burden Worldwide – The rising incidence of type 2 diabetes and obesity-related metabolic disorders is driving the demand for GLP-1-based treatments.
 - Advancements in Long-Acting Injectable Therapies – The introduction of once-weekly dosing has enhanced patient adherence and treatment outcomes.
 - Regulatory Approvals & Market Expansion – Global approvals from the FDA, EMA, and other regulatory bodies are expanding the market accessibility.
 - Growing Preference for Non-Insulin Therapies – Healthcare providers are increasingly recommending GLP-1 receptor agonists as first-line treatments for diabetes.
 
Trulicity Market Regional Trends
- North America leads because of its high diabetes prevalence, insurance coverage, and advanced healthcare infrastructure.
 - Europe is growing with government-supported healthcare initiatives and reimbursements programs.
 - The Asia-Pacific region is experiencing rapid adoption due to increasing awareness of diabetes and enhancements in healthcare access.
 - Latin America and MEA are emerging markets gaining greater access to innovative diabetes solutions treatments.
 
ClearView Market Insights Analysis;
The Trulicity Market is poised for strong growth, supported by rising diabetes cases, technological advancements in drug delivery, and expanding regulatory approvals. Companies investing in patient-centric innovations, extended formulations, and strategic partnerships will remain industry leaders
Reasons To Buy
                                 
                                 Scope
                                 
                              Key Players
- Eli Lilly and Company
 - Novo Nordisk A/S
 - AstraZeneca PLC
 - Sanofi S.A.
 - Pfizer Inc.
 - Boehringer Ingelheim
 - Takeda Pharmaceutical Company
 - Amgen Inc.
 - Teva Pharmaceuticals
 - Hanmi Pharmaceutical
 
Global Trulicity Market Report
- 1. Global Trulicity Market Research Report
	
- 1.1 Study Objectives
 - 1.2 Global Trulicity Market - Overview
 - 1.3 Reason to Read This Report
 - 1.4 Methodology and Forecast Analysis
 
- 2.1 Global Trulicity Market Research Report – Detailed Scope and Definitions
		
- 2.1.1 By Indication
 - 2.1.2 By Dosage Form
 - 2.1.3 By Dosage Strength
 - 2.1.4 By End-user
 - 2.1.5 By Region
 
 
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
 - 3.2. Restraints – By Indication, By Dosage Form, By Dosage Strength, By End-user, By Country
 - 3.3. Opportunities – By Indication, By Dosage Form, By Dosage Strength, By End-user, By Country
 - 3.4. Trends – By Indication, By Dosage Form, By Dosage Strength, By End-user, By Country
 - 3.5. PEST Analysis
 - 3.6. Porters Five Rule Analysis
 - 3.7. Company’s Share Analysis (CSA) by Region or By Country
 - 3.8. Global Trulicity Market Research Report – DROTs Impact Analysis
 
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
 - 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
 - 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
- 5.1 Type 2 Diabetes Mellitus (T2DM)
		
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 
- 6.1 Injectable Solution
		
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 
- 7.1 Trulicity 0.75 mg
		
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 - 7.2 Trulicity 1.5 mg
		
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 
- 8.1 Hospitals
		
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 - 8.2 Specialty Clinics
		
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 - 8.3 Retail Pharmacies
		
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 - 8.4 Online Pharmacies.
		
- 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 
- 9.1 North America
		
- 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 - 9.2 Europe
		
- 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 - 9.3 Asia-Pacific
		
- 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 - 9.4 Latin America
		
- 9.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 9.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 9.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 9.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 - 9.5 Middle East & Africa
		
- 9.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 9.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 9.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 9.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 - 9.6 Global Trulicity Market - Opportunity Analysis Index, By Indication, By Dosage Form, By Dosage Strength, By End-user, and Region, 2024 - 2031
 
- 10.1 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
- 10.1.1 Type 2 Diabetes Mellitus (T2DM)
 
- 10.2.1 Injectable Solution
 
- 10.3.1 Trulicity 0.75 mg
 - 10.3.2 Trulicity 1.5 mg
 
- 10.4.1 Hospitals
 - 10.4.2 Specialty Clinics
 - 10.4.3 Retail Pharmacies
 - 10.4.4 Online Pharmacies.
 
- 10.5.1 United States
 - 10.5.2 Canada
 
10.7 Regional Trends Analysis
10.8 North America Global Trulicity Market Research Report - Company Profiles- 10.8.1 Company 1 (United States)
 - 10.8.2 Company 2 (Canada)
 - 10.8.3 Company 3 (Canada)
 
 
- 11.1 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
- 11.1.1 Type 2 Diabetes Mellitus (T2DM)
 
- 11.2.1 Injectable Solution
 
- 11.3.1 Trulicity 0.75 mg
 - 11.3.2 Trulicity 1.5 mg
 
- 11.4.1 Hospitals
 - 11.4.2 Specialty Clinics
 - 11.4.3 Retail Pharmacies
 - 11.4.4 Online Pharmacies.
 
- 11.5.1 Germany
 - 11.5.2 United Kingdom
 - 11.5.3 France
 - 11.5.4 Spain
 - 11.5.5 Italy
 - 11.5.6 Russia
 - 11.5.7 Netherlands
 - 11.5.8 Poland
 - 11.5.9 Rest of Europe
 
11.7 Regional Trends Analysis
11.8 Europe Global Trulicity Market Research Report - Company Profiles- 11.8.1 Company 1 (Germany)
 - 11.8.2 Company 2 (United Kingdom)
 - 11.8.3 Company 3 (United Kingdom)
 
 
- 12.1 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
- 12.1.1 Type 2 Diabetes Mellitus (T2DM)
 
- 12.2.1 Injectable Solution
 
- 12.3.1 Trulicity 0.75 mg
 - 12.3.2 Trulicity 1.5 mg
 
- 12.4.1 Hospitals
 - 12.4.2 Specialty Clinics
 - 12.4.3 Retail Pharmacies
 - 12.4.4 Online Pharmacies.
 
- 12.5.1 China
 - 12.5.2 Japan
 - 12.5.3 India
 - 12.5.4 South Korea
 - 12.5.5 Australia & NZ
 - 12.5.6 ASEAN
 - 12.5.7 Rest of Asia-Pacific
 
12.7 Regional Trends Analysis
12.8 Asia-Pacific Global Trulicity Market Research Report - Company Profiles- 12.8.1 Company 1 (China)
 - 12.8.2 Company 2 (Japan)
 - 12.8.3 Company 3 (Japan)
 
 
- 13.1 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
- 13.1.1 Type 2 Diabetes Mellitus (T2DM)
 
- 13.2.1 Injectable Solution
 
- 13.3.1 Trulicity 0.75 mg
 - 13.3.2 Trulicity 1.5 mg
 
- 13.4.1 Hospitals
 - 13.4.2 Specialty Clinics
 - 13.4.3 Retail Pharmacies
 - 13.4.4 Online Pharmacies.
 
- 13.5.1 Brazil
 - 13.5.2 Mexico
 - 13.5.3 Argentina
 - 13.5.4 Peru
 - 13.5.5 Colombia
 - 13.5.6 Rest of Latin America
 
13.7 Regional Trends Analysis
13.8 Latin America Global Trulicity Market Research Report - Company Profiles- 13.8.1 Company 1 (Brazil)
 - 13.8.2 Company 2 (Mexico)
 - 13.8.3 Company 3 (Mexico)
 
 
- 14.1 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
- 14.1.1 Type 2 Diabetes Mellitus (T2DM)
 
- 14.2.1 Injectable Solution
 
- 14.3.1 Trulicity 0.75 mg
 - 14.3.2 Trulicity 1.5 mg
 
- 14.4.1 Hospitals
 - 14.4.2 Specialty Clinics
 - 14.4.3 Retail Pharmacies
 - 14.4.4 Online Pharmacies.
 
- 14.5.1 Saudi Arabia
 - 14.5.2 UAE
 - 14.5.3 South Africa
 - 14.5.4 Egypt
 - 14.5.5 Israel
 - 14.5.6 Rest of Middle East and Africa
 
14.7 Regional Trends Analysis
14.8 Middle East & Africa Global Trulicity Market Research Report - Company Profiles- 14.8.1 Company 1 (Saudi Arabia)
 - 14.8.2 Company 2 (UAE)
 - 14.8.3 Company 3 (UAE)
 
 
- 15.1 Strategic Dashboard of Top Market Players
15.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)- 15.2.1 Eli Lilly and Company
 - 15.2.2 Novo Nordisk A/S
 - 15.2.3 AstraZeneca PLC
 - 15.2.4 Sanofi S.A.
 - 15.2.5 Pfizer Inc.
 - 15.2.6 Boehringer Ingelheim
 - 15.2.7 Takeda Pharmaceutical Company
 - 15.2.8 Amgen Inc.
 - 15.2.9 Teva Pharmaceuticals
 - 15.2.10 Hanmi Pharmaceutical
 
 
17. Principal Presumptions and Acronyms